Literature DB >> 15629517

Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study.

Jesús Medina1, Paloma Sanz-Cameno, Luisa García-Buey, Samuel Martín-Vílchez, Manuel López-Cabrera, Ricardo Moreno-Otero.   

Abstract

BACKGROUND/AIMS: The intrahepatic inflammatory process occurring during primary biliary cirrhosis contributes to bile duct destruction, but the cellular and molecular pathways involved are largely unknown. Furthermore, additional pathogenetic mechanisms may exist. We aimed at evaluating the cellular infiltrate phenotype; the expression of lymphocyte activation, antigen recognition and cell-adhesion molecules; the occurrence of hepatic angiogenesis and the molecules involved.
METHODS: Immunohistochemical investigations were performed in frozen liver biopsy sections from primary biliary cirrhosis patients.
RESULTS: CD8+ and CD69+ T cells were predominant in inflammatory infiltrates around damaged cholangiocytes; beta2-microglobulin conformational epitope and intercellular adhesion molecule-1 expression were enhanced in bile ducts and hepatocytes. Inflamed portal areas showed vascular cell adhesion molecule-1 up-regulation; formation of tubule-like structures (neovessels) by endothelial cells expressing vascular endothelial-cadherin and CD-31; vascular endothelial growth factor expression in surrounding sinusoidal endothelial cells; and enhanced expression of angiopoietins 1 and 2, their receptor Tie-2 and endoglin, suggesting their involvement in new vascular structure formation.
CONCLUSIONS: The inflammatory infiltrate in primary biliary cirrhosis shows an increased reactivity for lymphocyte activation, antigen recognition and cell- and vascular-adhesion molecules. Additionally, intrahepatic angiogenesis occurs, involving vascular endothelial growth factor, angiopoietins 1 and 2, Tie-2 and endoglin in neovessel formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629517     DOI: 10.1016/j.jhep.2004.09.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

Review 1.  Regulators of Cholangiocyte Proliferation.

Authors:  Chad Hall; Keisaku Sato; Nan Wu; Tianhao Zhou; Konstantina Kyritsi; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Gene Expr       Date:  2016-07-12

2.  Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report.

Authors:  M Isabel Lucena; Raúl J Andrade; Luis Vicioso; F Jesús González; Ketevan Pachkoria; Beatriz García-Muñoz
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

Review 3.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 4.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 5.  Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver.

Authors:  Hiroyoshi Iguchi; Masaya Oda; Hitoshi Yamazaki; Hiroaki Yokomori
Journal:  Med Mol Morphol       Date:  2013-04-03       Impact factor: 2.309

6.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.

Authors:  Katryn Allen; Hartmut Jaeschke; Bryan L Copple
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases.

Authors:  Claudia Paternostro; Ezio David; Erica Novo; Maurizio Parola
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

8.  Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.

Authors:  Paloma Sanz-Cameno; María Trapero-Marugán; María Chaparro; Evan Anthony Jones; Ricardo Moreno-Otero
Journal:  J Oncol       Date:  2010-05-27       Impact factor: 4.375

9.  Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment.

Authors:  Mohamed Ahmed Abdelmoaty; Ahmed Mohamed Bogdady; Mervat Mohamed Attia; Nayel Abdelhamed Zaky
Journal:  Indian J Clin Biochem       Date:  2009-12-30

Review 10.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.